References
1. Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol [Internet]. 2018 Jan 20 [cited 2019 Aug 30];15(1):11–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28930295
2. Basaranoglu M, Neuschwander-Tetri BA. Nonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis. Gastroenterol Hepatol (N Y) [Internet]. 2006 Apr [cited 2019 Feb 24];2(4):282–91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28286458
3. Prins GH, Luangmonkong T, Oosterhuis D, Mutsaers HAM, Dekker FJ, Olinga P. A pathophysiological model of non-alcoholic fatty liver disease using precision-cut liver slices. Nutrients [Internet]. 2019 Mar 1 [cited 2021 Mar 20];11(3). Available from: https://pubmed.ncbi.nlm.nih.gov/30818824/
4. Vernon G, Baranova A, Younossi ZM. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther [Internet]. 2011 Aug 1 [cited 2019 Feb 22];34(3):274–85. Available from: http://doi.wiley.com/10.1111/j.1365-2036.2011.04724.x
5. VanWagner LB, Armstrong MJ. Lean NAFLD: A not so benign condition? Hepatol Commun [Internet]. 2018 [cited 2019 Feb 22];2(1):5–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29404505
6. Page LM, Girling JC. A novel cause for abnormal liver function tests in pregnancy and the puerperium: Non-alcoholic fatty liver disease. BJOG An Int J Obstet Gynaecol [Internet]. 2011 Nov 1 [cited 2021 May 29];118(12):1532–5. Available from: https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/j.1471-0528.2011.03070.x
7. McIntyre HD, Catalano P, Zhang C, Desoye G, Mathiesen ER, Damm P. Gestational diabetes mellitus [Internet]. Vol. 5, Nature Reviews Disease Primers. Nature Publishing Group; 2019 [cited 2021 Mar 21]. p. 1–19. Available from: https://www.nature.com/articles/s41572-019-0098-8
8. De Souza LR, Berger H, Retnakaran R, Vlachou PA, Maguire JL, Nathens AB, et al. Non-alcoholic fatty liver disease in early pregnancy predicts dysglycemia in mid-pregnancy: prospective study. Am J Gastroenterol [Internet]. 2016 May 1 [cited 2021 Apr 28];111(5):665–70. Available from: https://pubmed.ncbi.nlm.nih.gov/26977755/
9. Sattari M, Bril F, Egerman R, Kalavalapalli S, Cusi K. Relationship between non-alcoholic fatty liver disease during pregnancy and abnormal glucose metabolism during and after pregnancy. J Investig Med [Internet]. 2020 Mar 1 [cited 2021 May 29];68(3):743–7. Available from: https://pubmed.ncbi.nlm.nih.gov/31852748/
10. Sarkar M, Djerboua M, Flemming JA. NAFLD Cirrhosis Is Rising Among Childbearing Women and Is the Most Common Cause of Cirrhosis in Pregnancy. Clin Gastroenterol Hepatol [Internet]. 2021 Jan [cited 2021 May 29]; Available from: https://pubmed.ncbi.nlm.nih.gov/33465483/
11. Lee SM, Kwak SH, Koo JN, Oh IH, Kwon JE, Kim BJ, et al. Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus. Diabetologia [Internet]. 2018 Nov 23 [cited 2019 Jan 3];1–11. Available from: http://link.springer.com/10.1007/s00125-018-4779-8
12. HMM H, I K, TP W, G L. Prevalence and Associations of Non-Alcoholic Fatty Liver Disease (NAFLD) in Sri Lankan Patients With Type 2 Diabetes: A Single Center Study. Diabetes Metab Syndr. 2019;13(1).
13. Sarkar M, Grab J, Dodge JL, Gunderson EP, Rubin J, Irani RA, et al. Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes. J Hepatol. 2020 Sep 1;73(3):516–22.
14. Liu Y, Lu J, Xu M, Xu Y, Li M, Wang T, et al. Association between history of abortion and nonalcoholic fatty liver disease in middle-aged and elderly Chinese women. Ann Epidemiol. 2013 Mar;23(3):119–23.
15. Ajmera VH, Gunderson EP, VanWagner LB, Lewis CE, Carr JJ, Terrault NA. Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease. Am J Gastroenterol [Internet]. 2016 May 22 [cited 2019 Jan 30];111(5):658–64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27002796
16. Foghsgaard S, Andreasen C, Vedtofte L, Andersen ES, Bahne E, Strandberg C, et al. Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist Circumference. Diabetes Care [Internet]. 2017 [cited 2019 Jan 30];40:109. Available from: http://www.diabetesjournals
17. The Role of Non-Alcoholic Fatty Liver Disease in Gestational Diabetes - Full Text View - ClinicalTrials.gov [Internet]. [cited 2019 Jan 30]. Available from: https://clinicaltrials.gov/ct2/show/NCT01855386
18. Ajmera VH, Gunderson EP, VanWagner LB, Lewis CE, Carr JJ, Terrault NA. Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease. Am J Gastroenterol [Internet]. 2016 May 22 [cited 2019 Jan 28];111(5):658–64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27002796
19. NAFLD in pregnancy increases risks for mother and baby - EASL-The Home of Hepatology. [Internet]. [cited 2021 Feb 8]. Available from: https://easl.eu/press-release/nafld-pregnancy-risks/
20. Herath HMM, Kodikara I, Weerarathna TP, Liyanage G. Prevalence and associations of non-alcoholic fatty liver disease (NAFLD) in Sri Lankan patients with type 2 diabetes: A single center study. Diabetes Metab Syndr Clin Res Rev [Internet]. 2019 Jan [cited 2019 Jan 31];13(1):246–50. Available from: http://www.ncbi.nlm.nih.gov/pubmed/30641706
21. Rathi U, Bapat M, Rathi P, Abraham P. Effect of liver disease on maternal and fetal outcome–a prospective study. Indian J Gastroenterol [Internet]. [cited 2019 Mar 8];26(2):59–63. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17558066
22. Behboudi-Gandevani S, Amiri M, Bidhendi Yarandi R, Ramezani Tehrani F. The impact of diagnostic criteria for gestational diabetes on its prevalence: A systematic review and meta-analysis [Internet]. Vol. 11, Diabetology and Metabolic Syndrome. BioMed Central Ltd.; 2019 [cited 2021 May 29]. p. 11. Available from: https://doi.org/10.1186/s13098-019-0406-1
23. SM L, SH K, JN K, IH O, JE K, BJ K, et al. Non-alcoholic Fatty Liver Disease in the First Trimester and Subsequent Development of Gestational Diabetes Mellitus. Diabetologia. 2019;62(2).
24. Mi Lee S, Shin Park J, Norwitz ER, Nam Koo J, Hwan Oh I, Jae Kim B, et al. Nonalcoholic fatty liver disease in the first trimester as a risk factor for large-for-gestational-age birthweight: a prospective study [Internet]. Vol. 218, American Journal of Obstetrics and Gynecology. 2018 [cited 2019 Jan 30]. Available from: https://www.ajog.org/article/S0002-9378(17)32087-2/pdf
25. De Souza LR, Berger H, Retnakaran R, Vlachou PA, Maguire JL, Nathens AB, et al. Non-Alcoholic Fatty Liver Disease in Early Pregnancy Predicts Dysglycemia in Mid-Pregnancy: Prospective Study. Am J Gastroenterol [Internet]. 2016 May 15 [cited 2019 Jan 28];111(5):665–70. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26977755
26. Agampodi TC, Wickramasinghe ND, Prasanna RIR, Irangani MKL, Banda JMS, Jayathilake PMB, et al. The Rajarata Pregnancy Cohort (RaPCo): study protocol. BMC Pregnancy Childbirth. 2020 Dec;20(1):374.
27. MOMCH Unit, Regional Director of Health services, Anuradhapura SL. Annual Statistics. 2019.
28. Overview | Hypertension in pregnancy: diagnosis and management | Guidance | NICE. [cited 2019 Apr 26]; Available from: https://www.nice.org.uk/guidance/cg107
29. (PDF) Management of obesity [Internet]. [cited 2019 Mar 9]. Available from: https://www.researchgate.net/publication/301302217_Management_of_obesity
30. WHO recommendations on antenatal care for a positive pregnancy experience.
31. Lao TT. Implications of abnormal liver function in pregnancy and non-alcoholic fatty liver disease [Internet]. Vol. 68, Best Practice and Research: Clinical Obstetrics and Gynaecology. Bailliere Tindall Ltd; 2020 [cited 2021 May 28]. p. 2–11. Available from: https://pubmed.ncbi.nlm.nih.gov/32312689/
32. Mousa N, Abdel-Razik A, Shams M, Sheta T, Zakaria S, Shabana W, et al. Impact of non-alcoholic fatty liver disease on pregnancy. Br J Biomed Sci [Internet]. 2018 Oct 2 [cited 2019 Jan 28];75(4):197–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/29943682
33. Le MH, Devaki P, Ha NB, Jun DW, Te HS, Cheung RC, et al. Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States. Yu M-L, editor. PLoS One [Internet]. 2017 Mar 27 [cited 2019 Feb 22];12(3):e0173499. Available from: http://dx.plos.org/10.1371/journal.pone.0173499
34. De Souza LR, Berger H, Retnakaran R, Vlachou PA, Maguire JL, Nathens AB, et al. Hepatic fat and abdominal adiposity in early pregnancy together predict impaired glucose homeostasis in mid-pregnancy. Nutr Diabetes. 2016;6(9):e229.
35. Herath RP, Siriwardana SR, Ekanayake CD, Abeysekara V, Kodithuwakku SUA, Herath HP. Non-alcoholic fatty liver disease and pregnancy complications among Sri Lankan women: A cross sectional analytical study. Peterson JM, editor. PLoS One [Internet]. 2019 Apr 12 [cited 2020 Dec 1];14(4):e0215326. Available from: https://dx.plos.org/10.1371/journal.pone.0215326
36. Dahanayaka N, Agampodi S, Ranasinghe O, Jayaweera P, Wickramasinghe W, Adhikari A, et al. Inadequacy of the risk factor based approach to detect gestational diabetes mellitus. Ceylon Med J [Internet]. 2012 Mar 25 [cited 2019 Mar 30];57(1):5. Available from: https://cmj.sljol.info/article/10.4038/cmj.v57i1.4193/
37. International Association of Diabetes and Pregnancy Study Groups Consensus Panel M, Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010 Mar;33(3):676–82.
38. Hagström H, Höijer J, Ludvigsson JF, Bottai M, Ekbom A, Hultcrantz R, et al. Adverse outcomes of pregnancy in women with non-alcoholic fatty liver disease. Liver Int [Internet]. 2016 Feb [cited 2019 Jan 29];36(2):268–74. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26114995
39. Gastaldelli A. Fatty liver disease: The hepatic manifestation of metabolic syndrome [Internet]. Vol. 33, Hypertension Research. Nature Publishing Group; 2010 [cited 2021 Apr 29]. p. 546–7. Available from: www.nature.com/hr
40. Buzzetti E, Pinzani M, Tsochatzis EA. The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD). Metabolism [Internet]. 2016 Aug [cited 2019 Feb 24];65(8):1038–48. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26823198
41. Liu Y, Lu J, Xu M, Xu Y, Li M, Wang T, et al. Association between history of abortion and nonalcoholic fatty liver disease in middle-aged and elderly Chinese women. Ann Epidemiol [Internet]. 2013 Mar [cited 2021 Mar 9];23(3):119–23. Available from: https://pubmed.ncbi.nlm.nih.gov/23298439/
42. Misra A, Khurana L. The metabolic syndrome in South Asians: Epidemiology, determinants, and prevention. Metabolic Syndrome and Related Disorders. 2009.